Dabcyl-KTSAVLQSGFRKME-Edans TFA

Dabcyl-KTSAVLQSGFRKME-Edans TFA; 纯度: 99.48%

Dabcyl-KTSAVLQSGFRKME-Edans TFA 是一种荧光肽。Dabcyl-KTSAVLQSGFRKME-Edans TFA 用作底物,可测量蛋白酶的酶促活性。Dabcyl-KTSAVLQSGFRKME-Edans TFA 具有用于研究 2019-nCoV (COVID-19) 感染的潜力。

Dabcyl-KTSAVLQSGFRKME-Edans TFAamp;;

Dabcyl-KTSAVLQSGFRKME-Edans TFA Chemical Structure

规格 价格 是否有货
5 mg ¥10000 询问价格 货期

* Please select Quantity before adding items.

生物活性

Dabcyl-KTSAVLQSGFRKME-Edans TFA is a fluorogenic peptide. Dabcyl-KTSAVLQSGFRKME-Edans TFA is used as the substrate to measure the enzymatic activities of protease forms. Dabcyl-KTSAVLQSGFRKME-Edans TFA has the potential for study 2019-nCoV (COVID-19) infection[1][2][3].

体外研究
(In Vitro)

Recombinant 3CLpro is expressed in Pichia pastoris GS115 as a 42 kDa protein that displays a Km of 15 μM with Dabcyl-KTSAVLQSGFRKME-Edans TFA as substrate[1].
The Dabcyl-KTSAVLQSGFRKME-Edans TFA fluorogenic peptide is used as the substrate and the enhanced fluorescence due to cleavage of this substrate catalyzed by the protease is monitored at 538 nm with an excitation wavelength of 355 nm using a fluorescence plate reader[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Sequence

Dabcyl-Lys-Thr-Ser-Ala-Val-Leu-Gln-Ser-Gly-Phe-Arg-Lys-Met-Glu-Edans

Sequence Shortening

Dabcyl-KTSAVLQSGFRKME-Edans

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Protect from light, stored under nitrogen

Powder -80deg;C 2 years
-20deg;C 1 year

*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (protect from light, stored under nitrogen)

参考文献
  • [1]. Thi Thanh Hanh Nguyen, et al.Flavonoid-mediated Inhibition of SARS Coronavirus 3C-like Protease Expressed in Pichia Pastoris. Biotechnol Lett. 2012 May;34(5):831-8.

    [2]. Chih-Jung Kuo, et al.Engineering a Novel Endopeptidase Based on SARS 3CL(pro). Biotechniques. 2009 Dec;47(6):1029-32.

    [3]. Cheng-Wei Yang, et al.Novel Small-Molecule Inhibitors of Transmissible Gastroenteritis Virus. Antimicrob Agents Chemother. 2007 Nov;51(11):3924-31.